The Addition of Rituximab to First-Line Chemotherapy (R-CHOP) Results in Superior Response Rates, Time to Treatment Failure and Response Duration in Patients with Advanced Stage Mantle Cell Lymphoma: Long Term Results of a Randomized GLSG Trial

Autor: Hoster, Eva *, Unterhalt, Michael *, Wörmann, Bernhard *, Dührsen, Ulrich *, Metzner, Bernd, Eimermacher, Hartmut *, Neubauer, Andreas, Wandt, Hannes *, Steinhauer, Hjalmar *, Martin, Sonja *, Heidemann, Else *, Aldaoud, Ali *, Hiddemann, Wolfgang, Dreyling, Martin
Zdroj: In Blood 16 November 2008 112(11):3049-3049
Databáze: ScienceDirect